dc.contributor.author | Parker, PJ | |
dc.contributor.author | Lockwood, N | |
dc.contributor.author | Davis, K | |
dc.contributor.author | Kelly, JR | |
dc.contributor.author | Soliman, TN | |
dc.contributor.author | Pardo, AL | |
dc.contributor.author | Marshall, JJT | |
dc.contributor.author | Redmond, JM | |
dc.contributor.author | Vitale, M | |
dc.contributor.author | Silvia Martini | |
dc.date.accessioned | 2020-11-18T10:02:26Z | |
dc.date.available | 2020-10-02 | |
dc.date.available | 2020-11-18T10:02:26Z | |
dc.date.issued | 2020-12 | |
dc.identifier.citation | Peter J. Parker, Nicola Lockwood, Khalil Davis, Joanna R. Kelly, Tanya N. Soliman, Ainara Lopez Pardo, Jacqueline J.T. Marshall, Joanna M. Redmond, Marco Vitale, Silvia Martini, A cancer-associated, genome protective programme engaging PKCε, Advances in Biological Regulation, Volume 78, 2020, 100759, ISSN 2212-4926, https://doi.org/10.1016/j.jbior.2020.100759. | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68410 | |
dc.description.abstract | Associated with their roles as targets for tumour promoters, there has been a long-standing interest in how members of the protein kinase C (PKC) family act to modulate cell growth and division. This has generated a great deal of observational data, but has for the most part not afforded clear mechanistic insights into the control mechanisms at play. Here, we review the roles of PKCε in protecting transformed cells from non-disjunction. In this particular cell cycle context, there is a growing understanding of the pathways involved, affording biomarker and interventional insights and opportunities. | en_US |
dc.format.extent | 100759 - ? | |
dc.language | eng | |
dc.relation.ispartof | Advances in Biological Regulation | |
dc.rights | Open access article under the CC BY license | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Aurora B | en_US |
dc.subject | Cell cycle | en_US |
dc.subject | Non-disjunction | en_US |
dc.subject | PKCe | en_US |
dc.title | A cancer-associated, genome protective programme engaging PKCε. | en_US |
dc.type | Article | en_US |
dc.rights.holder | © 2020 The Authors. | |
dc.identifier.doi | 10.1016/j.jbior.2020.100759 | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/33039823 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 78 | en_US |
dcterms.dateAccepted | 2020-10-02 | |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |